These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33862102)

  • 1. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies.
    Chen Y; Chu F; Lin J; Su Z; Liao M; Li T; Li Y; Johnson N; Zheng H; Ding X
    J Ethnopharmacol; 2021 Jul; 275():114119. PubMed ID: 33862102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.
    Liu Z; Zheng Z; Wang T; Liu Z; Zuo Z
    J Pharm Pharmacol; 2024 May; 76(5):462-478. PubMed ID: 37832514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
    Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
    J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacological mechanism of Moluodan concentrated pill in the treatment of atrophic gastritis: A network pharmacological study and in vivo experiments.
    Lou N; Zhai M; Su Z; Chu F; Li Y; Chen Y; Liao M; Li P; Bo R; Meng X; Zhang P; Ding X
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116937. PubMed ID: 37480968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Mechanisms of Self-made Kuiyu Pingchang Recipe for the Treatment of Ulcerative Colitis and Irritable Bowel Syndrome using a Network Pharmacology-based Approach and Molecular Docking.
    Wen Y; Wang X; Si K; Xu L; Huang S; Zhan Y
    Curr Comput Aided Drug Des; 2024; 20(5):534-550. PubMed ID: 37190808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the potential targets of Biling Weitong Granules on visceral hypersensitivity through integration of network pharmacology and in vivo analysis.
    Yang Q; Zhao Y; Zhao X; Sun S; Chen Y; Chen J; Zou D; Zhang L
    J Ethnopharmacol; 2023 Nov; 316():116701. PubMed ID: 37257703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
    Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
    BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research in revealing the effects on Cuscuta chinensis to diarrhea type irritable bowel syndrome based on network pharmacology and molecular docking potential mechanism.
    Yang S; Liu H; Li K; Chen B; Tang Y; Li J; Wang D; Zhang X
    Medicine (Baltimore); 2024 May; 103(19):e38113. PubMed ID: 38728495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy.
    Li B; Rui J; Ding X; Chen Y; Yang X
    Phytomedicine; 2019 Oct; 63():152982. PubMed ID: 31299593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin.
    Cai T; Wang X; Li B; Xiong F; Wu H; Yang X
    Phytomedicine; 2021 Jun; 86():153527. PubMed ID: 33845366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder.
    Meng M; Bai C; Wan B; Zhao L; Li Z; Li D; Zhang S
    Biomed Res Int; 2021; 2021():4579850. PubMed ID: 34859100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.
    Li B; Rui J; Ding X; Yang X
    J Ethnopharmacol; 2019 Apr; 233():158-168. PubMed ID: 30590198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect and Mechanism of Sancao Lichang Decoction on Diarrhea- Predominant Irritable Bowel Syndrome by Regulating Tlr4/Myd88/Nf-Κb Pathway.
    Zhang P; Ma Y; Wang Z; Tang D
    Comb Chem High Throughput Screen; 2023; 26(13):2372-2379. PubMed ID: 36856180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology Analysis of the Mechanisms of Compound Herba Sarcandrae (Fufang Zhongjiefeng) Aerosol in Chronic Pharyngitis Treatment.
    Zhang Y; Yuan T; Li Y; Wu N; Dai X
    Drug Des Devel Ther; 2021; 15():2783-2803. PubMed ID: 34234411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network pharmacology approach to investigate the mechanism of Shuxuening injection in the treatment of ischemic stroke.
    Cui Q; Zhang YL; Ma YH; Yu HY; Zhao XZ; Zhang LH; Ge SQ; Zhang GW; Qin XD
    J Ethnopharmacol; 2020 Jul; 257():112891. PubMed ID: 32315738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network pharmacology evaluation of the active ingredients and potential targets of XiaoLuoWan for application to uterine fibroids.
    Yu Y; Yang F; Liu H
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33196098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
    Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
    Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways.
    Xie Y; Zhan X; Tu J; Xu K; Sun X; Liu C; Ke C; Cao G; Zhou Z; Liu Y
    J Ethnopharmacol; 2021 May; 272():113925. PubMed ID: 33592255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the pharmacological mechanisms of Shenlingbaizhu formula in antibiotic-associated diarrhea treatment: Network pharmacological analysis and experimental validation.
    Chen Y; Meng X; Zheng H; Gu Y; Zhu W; Wang S; Lin J; Li T; Liao M; Li Y; Guo S; Ding X
    J Ethnopharmacol; 2024 Jul; 329():118129. PubMed ID: 38582151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.
    He D; Li Q; Du G; Sun J; Meng G; Chen S
    Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.